I
Ichiro Takada
Researcher at Nihon University
Publications - 73
Citations - 5508
Ichiro Takada is an academic researcher from Nihon University. The author has contributed to research in topics: Transactivation & Adipogenesis. The author has an hindex of 30, co-authored 71 publications receiving 4996 citations. Previous affiliations of Ichiro Takada include Keio University & University of Tokyo.
Papers
More filters
Journal ArticleDOI
Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury.
Takashi Shichita,Yuki Sugiyama,Hiroaki Ooboshi,Hiroaki Ooboshi,Hiroshi Sugimori,Ryusuke Nakagawa,Ichiro Takada,Toru Iwaki,Yasunori Okada,Mitsuo Iida,Daniel J. Cua,Yoichiro Iwakura,Akihiko Yoshimura +12 more
TL;DR: It is demonstrated that the infiltration of T cells into the brain, as well as the cytokines interleukin-23 (IL-23) and IL-17, have pivotal roles in the evolution of brain infarction and accompanying neurological deficits, and proposed that T lymphocytes, including γδT lymphocyte, could be a therapeutic target for mitigating the inflammatory events that amplify the initial damage in cerebral ischemia.
Journal ArticleDOI
Dioxin receptor is a ligand-dependent E3 ubiquitin ligase
Fumiaki Ohtake,Atsushi Baba,Ichiro Takada,Maiko Okada,Kei Iwasaki,Hiromi Miki,Sayuri Takahashi,Alexander Kouzmenko,Keiko Nohara,Tomoki Chiba,Yoshiaki Fujii-Kuriyama,Shigeaki Kato +11 more
TL;DR: The findings uncover a function for AhR as an atypical component of the ubiquitin ligase complex and demonstrate a non-genomic signalling pathway in which fat-soluble ligands regulate target-protein-selective degradation through a ubiquitIn ligasecomplex.
Journal ArticleDOI
Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis.
TL;DR: Wnt and PPARγ signaling in MSCs and the crosstalk between these pathways are summarized and future clinical application of this knowledge is speculated on as the basis of novel approaches for regeneration therapy.
Journal ArticleDOI
Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
Kazuhiro Maeda,Yasuhiro Kobayashi,Nobuyuki Udagawa,Shunsuke Uehara,Akihiro Ishihara,Toshihide Mizoguchi,Yuichiro Kikuchi,Ichiro Takada,Shigeaki Kato,Shuichi Kani,Michiru Nishita,Keishi Marumo,T. John Martin,Yasuhiro Minami,Naoyuki Takahashi +14 more
TL;DR: The results suggest that the Wnt5a-Ror2 pathway is crucial for osteoclastogenesis in physiological and pathological environments and represents a therapeutic target for bone diseases, including arthritis.
Journal ArticleDOI
A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation.
Ichiro Takada,Masatomo Mihara,Masatomo Mihara,Miyuki Suzawa,Fumiaki Ohtake,Kobayashi Shinji,Mamoru Igarashi,Min Young Youn,Ken-ichi Takeyama,Takashi Nakamura,Yoshihiro Mezaki,Shinichiro Takezawa,Yoshiko Yogiashi,Hirochika Kitagawa,Gen Yamada,Shinji Takada,Yasuhiro Minami,Hiroshi Shibuya,Kunihiro Matsumoto,Shigeaki Kato +19 more
TL;DR: It is suggested that the non-canonical Wnt signalling pathway suppresses PPAR-γ function through chromatin inactivation triggered by recruitment of a repressing histone methyltransferase, thus leading to an osteoblastic cell lineage from mesenchymal stem cells.